Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 14745880

High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2004 Feb 1
First author
Hansmann A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2004 Aug 1;101(3):652; author reply 653. doi: 10.1002/cncr.20416.
    note
    Source null
    related pmid
    15274082
    relationship
    Comment in

Authors and identifiers

  1. name
    Hansmann A
    type
    Author
  2. name
    Adolph C
    type
    Author
  3. name
    Vogel T
    type
    Author
  4. name
    Unger A
    type
    Author
  5. name
    Moeslein G
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hansmann A
    type
    Author
  2. name
    Adolph C
    type
    Author
  3. name
    Vogel T
    type
    Author
  4. name
    Unger A
    type
    Author
  5. name
    Moeslein G
    type
    Author
bibliography ids
  1. nci-bib-420ff9964bcc029862a850c8
book metadata
content sha256
c04048d9d59116c66f89e7b772a4512229ae9dd80714064accd80e4f6dff2ccc
document type
citation
dois
  1. 10.1002/cncr.11937
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:14745880
immutable id
pubmed:14745880@c04048d9d59116c66f89e7b772a4512229ae9dd80714064accd80e4f6dff2ccc
journal
abbreviation
Cancer
issn electronic
Source null
issn print
0008-543X
issue
3
name
Cancer
nlm unique id
0374236
pages
612-20
volume
100
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2004 Aug 1;101(3):652; author reply 653. doi: 10.1002/cncr.20416.
    note
    Source null
    related pmid
    15274082
    relationship
    Comment in
outcomes validated
false
pmid
14745880
provenance
batch id
aee154f17d1b0501fe1f
provider
NCBI PubMed ESummary
record sha256
12701684490f5b7cc5cadcdbfd9179e0e26f991773a1a1c28866b0967ee2f997
response sha256
75a826407a9022d376294c7400982e19a458458cea55b2628fd3fddd75bc0f08
retrieved at
2026-09-09T23:45:53.270896+00:00
publication date
display
2004 Feb 1
precision
day
year
2004
publication types
  1. Comparative Study
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/14745880/
title
High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.

Preserved source evidence · Not medical advice